Optimized TracrolimuS and MMF for HLA Antibodies after Renal Transplantation (the OuTSMART study): a randomized controlled clinical trial to determine if a combined screening/treatment programme can prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies

Project: Research

Project Details

Effective start/end date1/12/201231/05/2022

Collaborative partners

  • King's College London (lead)
  • Central Manchester University Hospitals NHS Foundation Trust
  • Leeds and York Partnership NHS Foundation Trust
  • GSTT Guy's and St Thomas' NHS Foundation Trust
  • Barts Health NHS Trust
  • UCL University College London
  • University Hospitals Birmingham NHS Foundation Trust


  • NIHR National Institute For Health & Care Research: £246,325.00
  • NIHR National Institute For Health & Care Research: £2,362,494.00